- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1470-7330
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
How we read FCH-PET/CT for prostate cancer ; volume:16 ; number:1 ; day:6 ; month:12 ; year:2016 ; pages:1-11 ; date:12.2016
Cancer imaging ; 16, Heft 1 (6.12.2016), 1-11, 12.2016
- Urheber
-
Beauregard, Jean-Mathieu
- Beteiligte Personen und Organisationen
-
Beaulieu, Alexis
SpringerLink (Online service)
- DOI
-
10.1186/s40644-016-0101-5
- URN
-
urn:nbn:de:1111-201701034633
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Beauregard, Jean-Mathieu
- Beaulieu, Alexis
- SpringerLink (Online service)
Ähnliche Objekte (12)
How We Read Oncologic FDG PET/CT
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
[18F]DCFPyL PET/CT for imaging of prostate cancer
(18F) DCFPyL PET/CT for Imaging of Prostate Cancer
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Why we read history
Why we read Wikipedia
Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer
18F-DCFPyL PET/CT in primary staging of prostate cancer
How We Read Oncologic FDG PET/CT
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
[18F]DCFPyL PET/CT for imaging of prostate cancer
(18F) DCFPyL PET/CT for Imaging of Prostate Cancer
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Why we read history
Why we read Wikipedia
Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer
18F-DCFPyL PET/CT in primary staging of prostate cancer
How We Read Oncologic FDG PET/CT
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
[18F]DCFPyL PET/CT for imaging of prostate cancer
(18F) DCFPyL PET/CT for Imaging of Prostate Cancer
Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Why we read history
Why we read Wikipedia
Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer